Market Overview

Capitala Group Leads $27.3 Million Investment in Optio RX, LLC

Share:

Capitala Group ("Capitala"), a provider of capital to lower and
traditional middle market companies, announced today that it recently
originated a combination of a senior secured debt facility and minority
equity totaling $27.3 million to support Cold Bore Capital in the
formation of Optio RX, LLC ("Optio").

Based out of Nashville, TN, Optio is an owner and operator of specialty
compounding pharmacies and home infusion providers licensed across the
United States. Optio currently specializes in providing medication and
care in the fertility, veterinary and hemophilia segments. Capitala's
investment will help fund the company's next phase of growth as it looks
to acquire additional specialty pharmacies across the country.

About Capitala Group

Capitala Group is a $2.7 billion asset management firm that provides
capital to lower and traditional middle market businesses throughout
North America with office locations in Atlanta, Charlotte, Fort
Lauderdale, Los Angeles, New York, and Raleigh. Capitala's lower
middle market investment strategy
focuses on investing in debt
securities with minority equity co-investments with less than $250
million in enterprise value through its permanent capital vehicles,
Capitala Finance Corp. (NASDAQ:CPTA) and Capitala Specialty Lending
Corp. (CSLC). Capitala's growth fund strategy targets control and
minority equity investments, typically coupled with credit investments,
in lower middle market companies with less than $30 million in
enterprise value through both SBIC (CapitalSouth SBIC Fund IV, L.P.) and
non-SBIC closed-end funds. Capitala Group has invested in over 150
companies since its inception in 1998 and seeks to partner with strong
management teams to create value and achieve optimal outcomes for its
investors. For more information, visit our website at www.CapitalaGroup.com.

View Comments and Join the Discussion!